{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:52:02Z","timestamp":1793404322725,"version":"4.5.0"},"reference-count":152,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/ASMCopyrightv2"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Microbiol Rev"],"published-print":{"date-parts":[[2023,12,20]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n          <jats:p>Cryptococcal meningitis is a leading cause of morbidity and mortality globally, especially in people with advanced HIV disease. Cryptococcal meningitis is responsible for nearly 20% of all deaths related to advanced HIV disease, with the burden of disease predominantly experienced by people in resource-limited countries. Major advancements in diagnostics have introduced low-cost, easy-to-use antigen tests with remarkably high sensitivity and specificity. These tests have led to improved diagnostic accuracy and are essential for screening campaigns to reduce the burden of cryptococcosis. In the last 5 years, several high-quality, multisite clinical trials have led to innovations in therapeutics that have allowed for simplified regimens, which are better tolerated and result in less intensive monitoring and management of medication adverse effects. One trial found that a shorter, 7-day course of deoxycholate amphotericin B is as effective as the longer 14-day course and that flucytosine is an essential partner drug for reducing mortality in the acute phase of disease. Single-dose liposomal amphotericin B has also been found to be as effective as a 7-day course of deoxycholate amphotericin B. These findings have allowed for simpler and safer treatment regimens that also reduce the burden on the healthcare system. This review provides a detailed discussion of the latest evidence guiding the clinical management and special circumstances that make cryptococcal meningitis uniquely difficult to treat.<\/jats:p>","DOI":"10.1128\/cmr.00156-22","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T14:01:29Z","timestamp":1701180089000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":46,"title":["Diagnosis and management of cryptococcal meningitis in HIV-infected adults"],"prefix":"10.1128","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7226-3075","authenticated-orcid":true,"given":"Thomas C.","family":"McHale","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4715-0060","authenticated-orcid":true,"given":"David R.","family":"Boulware","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kasibante","sequence":"additional","affiliation":[{"name":"Infectious Diseases Institute, Makerere University, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8125-0698","authenticated-orcid":false,"given":"Kenneth","family":"Ssebambulidde","sequence":"additional","affiliation":[{"name":"Infectious Diseases Institute, Makerere University, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0000-8876","authenticated-orcid":true,"given":"Caleb P.","family":"Skipper","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Abassi","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz506"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00499-6"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30243-8"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz488"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit794"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1086\/587667"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002095"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-013-9476-1"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/313603"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16301-0"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30442-6"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2001.130906"},{"key":"e_1_3_1_16_2","unstructured":"NIH. 2021. Cryptococcosis. Available from: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections\/cryptococcosis. Retrieved 15 Apr 2023."},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000384"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa016"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myv104"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1305981"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir745"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2011.10.014"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283536a93"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328354b419"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/593194"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00074-8"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1086\/649861"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1710922"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2111904"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.135.9.1155"},{"key":"e_1_3_1_31_2","first-page":"91","article-title":"High mortality despite high-dose oral fluconazole (1600 mg) and flucytosine, and serial lumbar punctures, for HIV-associated cryptococcal meningitis: ANRS 12257 study in Burundi and Ivory coast","volume":"20","author":"Chabrol A","year":"2017","unstructured":"Chabrol A, Doumbia A, Landman R, Fontanet A, Eholie SP, Niyongabo T, Nizigama L, Laureillard D, Sylla B, Menan H, Padoin C, Brun S, Alloui C, Gibowski S, Kakou A, Bouchaud O, Anrs Study Grp. 2017. High mortality despite high-dose oral fluconazole (1600 mg) and flucytosine, and serial lumbar punctures, for HIV-associated cryptococcal meningitis: ANRS 12257 study in Burundi and Ivory coast. J Int AIDS Soc 20:91.","journal-title":"J Int AIDS Soc"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00446-12"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir613"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02421-20"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190652"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02046-19"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ263"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01683-14"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00860-21"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1086\/432073"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit641"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/18.5.789"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2008.00645.x"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2007.01874.x"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac599"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60164-7"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofu105"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit808"},{"key":"e_1_3_1_49_2","volume-title":"Serological assays for the detection of beta-glucan - class II special controls guidance document for industry and FDA staff","author":"U.S. Food and Drug Administration","year":"2021","unstructured":"U.S. Food and Drug Administration. 2021. Serological assays for the detection of beta-glucan - class II special controls guidance document for industry and FDA staff. FDA."},{"key":"e_1_3_1_50_2","unstructured":"MiraVista Diagnostics. 2023. Beta-D-glucan assay diagnostic test. MiraVista Diagn. Available from: https:\/\/miravistalabs.com\/medical-fungal-infection-testing\/antigen-detection\/beta-d-glucan-test. Retrieved 7 Apr 2023."},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2015.11.017"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.01.007"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1086\/649858"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.3390\/jof5030065"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-3019(90)90198-x"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix1143"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz485"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1086\/655143"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001894"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix613"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001899"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001669"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix872"},{"key":"e_1_3_1_64_2","unstructured":"Govender N St. George\u2019s University of. 2023. Effect trial: treatment of cryptococcal antigen-positive patients identified through screening using fluconazole plus flucytosine vs fluconazole alone. Available from: https:\/\/www.isrctn.com\/ISRCTN30579828. Retrieved 14 Apr 2023."},{"key":"e_1_3_1_65_2","unstructured":"Meya D. 2023. Evaluation of CrAg screening with enhanced antifungal therapy for asymptomatic CrAg+ persons. NCT03945448. Clinical trial registration. clinicaltrials.gov"},{"key":"e_1_3_1_66_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1409052"},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01238-18"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.1080\/21501203.2010.487054"},{"key":"e_1_3_1_69_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00212-12"},{"key":"e_1_3_1_70_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac792"},{"key":"e_1_3_1_71_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2011.00944_1.x"},{"key":"e_1_3_1_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12878"},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.1086\/653606"},{"key":"e_1_3_1_74_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit099"},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2006.01293.x"},{"key":"e_1_3_1_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2016.08.004"},{"key":"e_1_3_1_77_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.68929"},{"key":"e_1_3_1_78_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021334"},{"key":"e_1_3_1_79_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040573"},{"key":"e_1_3_1_80_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509024"},{"key":"e_1_3_1_81_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02063-17"},{"key":"e_1_3_1_82_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy083"},{"key":"e_1_3_1_83_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv157"},{"key":"e_1_3_1_84_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199707033370103"},{"key":"e_1_3_1_85_2","first-page":"293","article-title":"The efficacy of fluconazole 600 mg\/day versus itraconazole 600 mg\/day as consolidation therapy of cryptococcal meningitis in AIDS patients","volume":"86","author":"Mootsikapun P","year":"2003","unstructured":"Mootsikapun P, Chetchotisakd P, Anunnatsiri S, Choksawadphinyo K. 2003. The efficacy of fluconazole 600 mg\/day versus itraconazole 600 mg\/day as consolidation therapy of cryptococcal meningitis in AIDS patients. J Med Assoc Thail Chotmaihet Thangphaet 86:293\u2013298.","journal-title":"J Med Assoc Thail Chotmaihet Thangphaet"},{"key":"e_1_3_1_86_2","doi-asserted-by":"publisher","DOI":"10.3109\/23744235.2015.1044260"},{"key":"e_1_3_1_87_2","doi-asserted-by":"publisher","DOI":"10.3109\/13693786.2012.715763"},{"key":"e_1_3_1_88_2","volume-title":"Clin lab stand Inst","author":"Alexander BD","year":"2017","unstructured":"Alexander BD, Procop GW, Dufresne P, Fuller J, Ghannoum M, Hanson K, Holliday D, Holliday N, Kovanda L, Lockhart S, Ostrosky-Zeichner L, Scheutz A, Wiederhold N, Zelazny A. 2017. M27: reference method for broth dilution antifungal susceptibility testing of yeasts. In Clin lab stand Inst, 4th edition. https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m27.","edition":"4"},{"key":"e_1_3_1_89_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2007.01935.x"},{"key":"e_1_3_1_90_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199102283240902"},{"key":"e_1_3_1_91_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199203193261203"},{"key":"e_1_3_1_92_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201093260202"},{"key":"e_1_3_1_93_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832605fe"},{"key":"e_1_3_1_94_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac416"},{"key":"e_1_3_1_95_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu596"},{"key":"e_1_3_1_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2014.10.007"},{"key":"e_1_3_1_97_2","doi-asserted-by":"publisher","DOI":"10.1258\/0049475053001967"},{"key":"e_1_3_1_98_2","doi-asserted-by":"publisher","DOI":"10.1086\/342299"},{"key":"e_1_3_1_99_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofu070"},{"key":"e_1_3_1_100_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/33.2.203"},{"key":"e_1_3_1_101_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01698-15"},{"key":"e_1_3_1_102_2","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12387"},{"key":"e_1_3_1_103_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.2.171"},{"key":"e_1_3_1_104_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1472-8206.2002.00064.x"},{"key":"e_1_3_1_105_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt508"},{"key":"e_1_3_1_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90691-7"},{"key":"e_1_3_1_107_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.2.3.114"},{"key":"e_1_3_1_108_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.10.029"},{"key":"e_1_3_1_109_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01127-8"},{"key":"e_1_3_1_110_2","doi-asserted-by":"publisher","DOI":"10.3109\/15569527.2015.1020544"},{"key":"e_1_3_1_111_2","doi-asserted-by":"publisher","DOI":"10.1086\/588844"},{"key":"e_1_3_1_112_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00838-20"},{"key":"e_1_3_1_113_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00724-19"},{"key":"e_1_3_1_114_2","unstructured":"Full Text View - ClinicalTrials.gov. 2023. Encochleated oral amphotericin for cryptococcal meningitis trial 3. Available from: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05541107. Retrieved 18 Aug 2023."},{"key":"e_1_3_1_115_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad440"},{"key":"e_1_3_1_116_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-021-00511-0"},{"key":"e_1_3_1_117_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00286-20"},{"key":"e_1_3_1_118_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02364-18"},{"key":"e_1_3_1_119_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.6.1437"},{"key":"e_1_3_1_120_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00523-18"},{"key":"e_1_3_1_121_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02717-w"},{"key":"e_1_3_1_122_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005575"},{"key":"e_1_3_1_123_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70170-5"},{"key":"e_1_3_1_124_2","doi-asserted-by":"publisher","DOI":"10.1086\/428618"},{"key":"e_1_3_1_125_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e32835c21d1"},{"key":"e_1_3_1_126_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit019"},{"key":"e_1_3_1_127_2","doi-asserted-by":"publisher","DOI":"10.1086\/652652"},{"key":"e_1_3_1_128_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad122"},{"key":"e_1_3_1_129_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad123"},{"key":"e_1_3_1_130_2","doi-asserted-by":"publisher","DOI":"10.1086\/507897"},{"key":"e_1_3_1_131_2","doi-asserted-by":"publisher","DOI":"10.3109\/13693781003774689"},{"key":"e_1_3_1_132_2","doi-asserted-by":"publisher","DOI":"10.1086\/313992"},{"key":"e_1_3_1_133_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.3.611"},{"key":"e_1_3_1_134_2","first-page":"792","article-title":"Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia","volume":"43","author":"Stephen C","year":"2002","unstructured":"Stephen C, Lester S, Black W, Fyfe M, Raverty S. 2002. Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. Can Vet J 43:792\u2013794.","journal-title":"Can Vet J"},{"key":"e_1_3_1_135_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.05427-0"},{"key":"e_1_3_1_136_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1602.090900"},{"key":"e_1_3_1_137_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1508.081384"},{"key":"e_1_3_1_138_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit341"},{"key":"e_1_3_1_139_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis529"},{"key":"e_1_3_1_140_2","unstructured":"US Food and Drug Administration. 2011. FDA drug safety communication: use of long-term high-dose diflucan (fluconazole) during pregnancy may be associated with birth defects in infants"},{"key":"e_1_3_1_141_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku355"},{"key":"e_1_3_1_142_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1312226"},{"key":"e_1_3_1_143_2","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myz084"},{"key":"e_1_3_1_144_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90354-j"},{"key":"e_1_3_1_145_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.6.1383"},{"key":"e_1_3_1_146_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0732-8893(98)00095-9"},{"key":"e_1_3_1_147_2","doi-asserted-by":"publisher","DOI":"10.1086\/507895"},{"key":"e_1_3_1_148_2","doi-asserted-by":"publisher","DOI":"10.1086\/342384"},{"key":"e_1_3_1_149_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00069-19"},{"key":"e_1_3_1_150_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328358daea"},{"key":"e_1_3_1_151_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx274"},{"key":"e_1_3_1_152_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy122"},{"key":"e_1_3_1_153_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy817"},{"key":"e_1_3_1_154_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad156"},{"key":"e_1_3_1_155_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy1024"}],"container-title":["Clinical Microbiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/cmr.00156-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/cmr.00156-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T23:39:03Z","timestamp":1715816343000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/cmr.00156-22"}},"subtitle":[],"editor":[{"given":"Graeme N.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":152,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12,20]]}},"alternative-id":["10.1128\/cmr.00156-22"],"URL":"https:\/\/doi.org\/10.1128\/cmr.00156-22","relation":{},"ISSN":["0893-8512","1098-6618"],"issn-type":[{"value":"0893-8512","type":"print"},{"value":"1098-6618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,20]]},"assertion":[{"value":"2023-11-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00156-22"}}